Critical Path Institute (C-Path)
Kimberly Collins is an experienced professional in the field of pharmacometrics, currently serving as a Senior Quantitative Medicine Scientist at the Critical Path Institute since January 2021. In addition to this role, Kimberly serves as President of the NATURAAL Program and has been a pianist for various church organizations since 2006. Previously, Kimberly held positions at the Indiana University School of Medicine as an Assistant Scientist and Postdoctoral Fellow in the Departments of Medicine and Clinical Pharmacology. Academic credentials include a PhD in Pharmacology and Toxicology from Indiana University School of Medicine, along with a Fellowship in Clinical Pharmacology and a Graduate Certificate in Clinical Research. Additional experience includes research positions at Eli Lilly and Company, the University of Alabama at Birmingham, and the University of Wisconsin-Madison, contributing to a diverse background in clinical pharmacology and toxicology research.
This person is not in any offices
Critical Path Institute (C-Path)
Critical Path Institute (C-Path) is an independent, nonprofit organization established in 2005 as a public and private partnership. C-Path’s mission is to catalyze the development of new approaches that advance medical innovation and regulatory science, accelerating the path to a healthier world. An international leader in forming collaborations, C-Path has established numerous global consortia that currently include more than 1,600 scientists from government and regulatory agencies, academia, patient organizations, disease foundations, and dozens of pharmaceutical and biotech companies. C-Path U.S. is headquartered in Tucson, Arizona and C-Path, Ltd. EU is headquartered in Dublin, Ireland, with additional staff in multiple other locations. For more information, visit c-path.org and c-path.eu.